无法在这个位置找到： ”baidu_js_push.htm”
今日热点推荐：
爱地那非是什么？悦康“爱力士”
加入收藏 | 设为首页 | 热门搜索 |
网站地图
再获5000万美元融资！拼热度 巨噬细胞就没有输过(2)
2020-02-21 未知 admin
在CD47与PSGL-1之外，还有哪些靶点能有效调控巨噬细胞的活性？从这些靶点出发，又会诞生多少造福患者的创新疗法？我们拭目以待。
参考资料：[1] Verseau Launches with $50 Million to Develop First-in-Class Macrophage-Targeted Immunotherapies and Appoints George Golumbeski as Chairman of the Board, Retrieved October 21, 2019, from https://www.businesswire.com/news/home/20191020005075/en/Verseau-Launches-50-Million-Develop-First-in-Class-Macrophage-Targeted[2] Luca Cassetta and Jeffrey W. Pollard, (2019), Targeting macrophages: therapeutic approaches in cancer, Nature Reviews Drug Discovery, DOI: https://doi.org/10.1038/nrd.2018.169
鐑瘝锛�
